• HRP Rabbit Anti-Goat IgG (H+L) Antibody Guide

  2026-08-15

  Build sensitive, adaptable workflows for detecting goat primary antibodies in western blotting, ELISA, dot blotting, and tissue staining. This guide connects localized p21 mRNA–LNP bladder cancer research with practical assay design, dilution selection, controls, and troubleshooting.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-14

  The reference study identifies nitric oxide signaling as a mechanistic link between puerarin exposure and osteogenic differentiation in rat dental follicle cells. Its inhibitor-based design shows that blocking NOS activity with L-NMMA reverses puerarin-associated increases in osteogenic markers, supporting nitric oxide pathway modulation as a research direction for periodontal regeneration.

• Polygodial for TRPA1 Assay Workflows

  2026-08-14

  Polygodial provides a practical chemical entry point for TRPA1 ion channel modulation, from rapid calcium-imaging assays to epithelial inflammatory-signaling studies. This workflow connects channel-proximal measurements with Ca2+/NFAT and TSLP readouts while emphasizing solvent control, orthogonal validation, and compound-handling discipline.

• Amiloride (MK-870): Mechanism and Research Limits

  2026-08-13

  Amiloride (MK-870) is an epithelial sodium channel inhibitor used to investigate sodium influx, ion transport, and receptor-linked cellular processes. Product information identifies BA2768 as a solid with a molecular weight of 229.63 g/mol, while a 2018 entry study found that amiloride did not inhibit grass carp reovirus entry under its tested conditions.

• Genistein A2198: Reliable Assay Design

  2026-08-13

  This scenario-based guide explains how Genistein (SKU A2198) can help researchers design interpretable cell viability, proliferation, and cytotoxicity experiments. It connects concentration benchmarks, solvent handling, orthogonal readouts, and supplier-selection criteria to practical cancer biology workflows.

• Palmitic acid: Practical Protocol and QC Guide

  2026-08-12

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a characterized saturated long-chain fatty acid for controlled metabolic, inflammatory, lipid, and protein palmitoylation workflows. It is unsuitable for direct aqueous preparation or long-term solution storage, so solvent selection, vehicle controls, and prompt use are essential.

• EZ Cap™ EGFP mRNA (5-moUTP) Assay Guide

  2026-08-12

  A scenario-driven guide to using EZ Cap™ EGFP mRNA (5-moUTP), SKU R1016, to separate transfection and translation effects from cell viability, proliferation, and cytotoxicity measurements. It combines product specifications, practical handling guidance, and recent mRNA/LNP evidence to support more interpretable and reproducible assays.

• ALDH2–APC Synthetic Lethality in Colorectal Cancer

  2026-08-11

  Liang et al. identify aldehyde dehydrogenase 2 (ALDH2) inhibition as a vulnerability of APC-deficient colorectal cancer, linking Disulfiram treatment to ROS accumulation and ASK1/JNK-driven apoptosis. The study provides a genotype-informed framework for cancer research, while also highlighting the need to distinguish ALDH2-dependent effects from Disulfiram’s other biochemical activities.

• Metabolic Sensitization of Ferroptosis and Cuproptosis

  2026-08-11

  The reference study develops a Cu–tannic acid/liposome nanosystem carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism, thereby increasing tumor-cell susceptibility to ferroptosis and cuproptosis. Its broader contribution is to connect metabolic depletion, regulated cell death, immunogenic cell death, and tumor immune remodeling in one therapeutic design.

• Functional Metagenomics Reveals Cas9 Inhibitors

  2026-08-10

  Forsberg et al. developed a functional metagenomic selection that identified anti-CRISPR proteins directly from human oral and fecal microbiomes. The study revealed AcrIIA11 as a potent, mechanistically distinct SpyCas9 inhibitor with activity in bacteria and human cells, demonstrating how phenotype-based screening can expand anti-CRISPR discovery beyond sequence annotation.

• CKI 7 Dihydrochloride in CK1 Pathway Studies

  2026-08-09

  CKI 7 dihydrochloride is a Casein kinase 1 inhibitor for dissecting Wnt, circadian, DNA repair, and cancer-associated signaling. This guide presents a causal assay strategy that connects CK1 perturbation with, but does not conflate it with, the MAPK10–KRT16 metastasis axis.

• Glycogen Colorimetric Assay Kit II Workflow

  2026-08-08

  Turn circadian exercise experiments into actionable glycogen data with a practical, interference-aware workflow. The Glycogen Colorimetric Assay Kit II supports sensitive tissue and cell measurements while offering a scalable route from pilot assays to high-throughput metabolic studies.

• Doxycycline-Inducible EMT in MCF10A Cells

  2026-08-07

  Sun, Zhou, and Hu established a reversible doxycycline-inducible Twist1 system that drives epithelial-to-mesenchymal transition in MCF10A mammary epithelial cells. The model provides a controlled alternative to cytokine-induced EMT and a practical platform for testing whether cancer-associated genes influence metastasis through EMT-related mechanisms.

• Rucaparib (AG-014699): Mechanisms and Benchmarks in DNA Repa

  2026-08-07

  Rucaparib (AG-014699) is a highly potent PARP1 inhibitor with a Ki of 1.4 nM, providing a robust research tool for dissecting DNA damage and repair pathways. Its radiosensitization properties are especially pronounced in DNA repair-deficient and prostate cancer cell models. Product-specific data from APExBIO and peer-reviewed studies substantiate its selectivity, cellular effects, and transport dynamics.

• Exendin-4: Rethinking Access and Innovation in Diabetes Rese

  2026-08-06

  Exendin-4 (Exenatide) is at the forefront of next-generation type 2 diabetes research, offering mechanistic precision as a GLP-1 receptor agonist and inspiring new, accessible manufacturing paradigms. This thought-leadership article unpacks the molecular rationale, experimental strategies, and translational possibilities enabled by Exendin-4, including the disruptive potential of yeast-based expression systems. Drawing on recent open-access studies and industry-validated workflows, we frame a strategic vision for translational scientists seeking to improve insulin sensitivity, reverse hepatic steatosis, and scale global access to diabetes therapeutics.

15520 records 1/1035 page Next 12345 下5页 Last page